Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

Share Price is delayed by 15 minutes
Get Live Data
1,916.50    -21.50 (-1.11%)
Bid:
1,916.00
Ask:
1,916.50
Spread: 0.50 (0.026%)
Market Cap: £76.86b
GSK Live PriceLast checked at - London Stock Exchange

Intraday Glaxosmithkline Share Chart

Glaxosmithkline News

Trials show GSK drug cures hepatitis B in nearly 20% of patients
28 May 2026

Trials show GSK drug cures hepatitis B in nearly 20% of patients

(Sharecast News) - GSK said on Thursday that late-stage trial results for its experimental drug for chronic hepatitis B, bepirovirsen, showed that it ...

GSK hails "major step forward" after "positive" hepatitis drug results
28 May 2026

GSK hails "major step forward" after "positive" hepatitis drug results

(Alliance News) - GSK PLC on Thursday reported "positive" phase 3 trial data for its hepatitis B treatment, Bepirovirsen, which it said could "redefin...

GSK's chronic hepatitis B drug helps one in five achieve functional cure in key studies
28 May 2026

GSK's chronic hepatitis B drug helps one in five achieve functional cure in key studies

* GSK's drug helps 19% of patients achieve functional cure ​across ⁠two studies

Citi sees buying opportunity at AstraZeneca after recent falls
18 May 2026

Citi sees buying opportunity at AstraZeneca after recent falls

(Sharecast News) - Analysts at Citi have reiterated a 'buy' rating on AstraZeneca and a 'neutral' on GSK following the European pharma sector's first-...

GSK's RSV vaccine Arexvy approved in Japan for some adults under 50
18 May 2026

GSK's RSV vaccine Arexvy approved in Japan for some adults under 50

(Alliance News) - GSK PLC on Monday announced that Japan's Ministry of Health, Labour & Welfare expanded the eligible population for its respiratory s...

WINNERS & LOSERS: Miners slide; Centrica to pay GBP20 million to Ofgem
15 May 2026

WINNERS & LOSERS: Miners slide; Centrica to pay GBP20 million to Ofgem

(Alliance News) - The following are the leading risers and fallers among FTSE 100 and 250 index constituents on Friday.

GSK agrees China hepatitis B deal as kicks off last tranche of buyback
11 May 2026

GSK agrees China hepatitis B deal as kicks off last tranche of buyback

(Alliance News) - GSK PLC on Monday launched the fifth tranche of its GBP2.0 billion buyback as it announced an exclusive collaboration with China pha...

GSK strikes agreement with China's SBP Group, launches final tranche of buyback programme
11 May 2026

GSK strikes agreement with China's SBP Group, launches final tranche of buyback programme

(Sharecast News) - Drugmaker GSK said on Monday that it has struck an exclusive agreement with Sino Biopharmaceutical subsidiary Chia Tai Tianqing Pha...